Yiqing Xu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Epidermal Growth Factor Receptor

Patient Reported Outcomes

End Stage Renal Disease

Top Venues

JCO global oncology

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Wu, Yunhong Wu, Vijaya Natarajan, Prabhsimranjot Singh, Waseem Cheema, Rukhsana Hossain, Christine Liu, Yocasta Mejia, Myoe Htet Htet Oo, Bina Valenzano, Yiqing Xu
Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background. JCO global oncology 9 (2023)
Alex Wu, Yunhong Wu, Vijaya Natarajan, Prabhsimranjot Singh, Waseem Cheema, Rukhsana Hossain, Christine Liu, Yocasta Mejia, Myoe Htet Htet Oo, Bina Valenzano, Yiqing Xu
Complementary and Alternative Medicine Use in Patients With Cancer and Immigration Background. JCO global oncology 9 (2023)
Pooja Gogia, Yiqing Xu
Transient Complete Recovery of Chronic Refractory Idiopathic Thrombocytopenic Purpura after Treatment with Monoclonal Antibody Targeting SARS-CoV-2 Spike Protein. Case reports in hematology 2022 (2022)
Rajat Thawani, Srikant Nannapaneni, Vivek Kumar, Phone Oo, Michael Simon, Anna Huang, Ishan Malhotra, Yiqing Xu
Prediction of Heparin Induced Thrombocytopenia (HIT) Using a Combination of 4Ts Score and Screening Immune Assays. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 26 (2021)